Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
Not yet recruiting · NCT07611513 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). | Echovirus infectious disease, Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, herpangina, viral infectious disease | Not yet recruiting | Phase 3 | 2026-05-28 | NCT07611513 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sinovac Biotech Co., Ltd | 19 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Center for Disease Control and Prevention | Hefei | China | 3 |
| Fujian Provincial Center for Disease Control and Prevention | Fujian | China | 2 |
| Henan Provincial Center for Disease Control and Prevention | Henan | China | 1 |
| Hubei Provincial Center for Disease Control and Prevention | Hubei | China | 2 |
| Sichuan Provincial Center for Disease Control and Prevention | Sichuan | China | 1 |